IPSC
Investing in Century Therapeutics Inc (IPSC) Is Getting More Attractive
Roman Campbell
Century Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Cowan Chad acquired Company’s shares for reported $49252.0 on ...
Century Therapeutics Inc (IPSC) Becoming More Attractive for Investors
Samantha Gray
Century Therapeutics Inc’s filing revealed that its Chief Scientific Officer Cowan Chad acquired Company’s shares for reported $49252.0 on Dec ...
Investing in Century Therapeutics Inc (IPSC): What You Must Know
Jaxson Clark
Century Therapeutics Inc’s recently made public that its President and CEO Pfeiffenberger Brent acquired Company’s shares for reported $30352.0 on ...
Investing in Century Therapeutics Inc (IPSC): What You Must Know
Jaxson Clark
Century Therapeutics Inc’s recently made public that its President and CEO Pfeiffenberger Brent acquired Company’s shares for reported $30352.0 on ...
